Acromegaly Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
Conditions:   Acromegaly;   GEP-NET Interventions:   Drug: Debio 4126;   Drug: Sandostatin LAR;   Drug: Somatuline ATG Sponsor:   Debiopharm International SA Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2022 Category: Research Source Type: clinical trials